KRAS and neoplasm: Mechanistically, KDM7B upregulated the expression of PD-L1, KRAS, BRAF, and c-Myc and promoted immune escape and tumor progression by increasing the levels of H3K4me3 and H3K27ac and decreasing the level of H3K9me2 [172].